- Home
- WISA vs CLRB Comparison
WISA vs CLRB Comparison
Compare WISA & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WISA
- CLRB
- Stock Information
- Founded
- WISA 2010
- CLRB 2002
- Country
- WISA United States
- CLRB United States
- Employees
- WISA N/A
- CLRB N/A
- Industry
- WISA Semiconductors
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- WISA Technology
- CLRB Health Care
- Exchange
- WISA Nasdaq
- CLRB Nasdaq
- Market Cap
- WISA 13.4M
- CLRB 10.7M
- IPO Year
- WISA 2018
- CLRB N/A
- Fundamental
- Price
- WISA $1.69
- CLRB $0.25
- Analyst Decision
- WISA Strong Buy
- CLRB Buy
- Analyst Count
- WISA 1
- CLRB 2
- Target Price
- WISA $11.00
- CLRB $28.00
- AVG Volume (30 Days)
- WISA 269.1K
- CLRB 3.9M
- Earning Date
- WISA 11-15-2024
- CLRB 11-18-2024
- Dividend Yield
- WISA N/A
- CLRB N/A
- EPS Growth
- WISA N/A
- CLRB N/A
- EPS
- WISA N/A
- CLRB N/A
- Revenue
- WISA $2,192,000.00
- CLRB N/A
- Revenue This Year
- WISA $10.18
- CLRB N/A
- Revenue Next Year
- WISA $166.67
- CLRB N/A
- P/E Ratio
- WISA N/A
- CLRB N/A
- Revenue Growth
- WISA N/A
- CLRB N/A
- 52 Week Low
- WISA $1.15
- CLRB $0.23
- 52 Week High
- WISA $21.00
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- WISA 48.33
- CLRB 5.84
- Support Level
- WISA $1.56
- CLRB $0.23
- Resistance Level
- WISA $1.78
- CLRB $0.28
- Average True Range (ATR)
- WISA 0.10
- CLRB 0.07
- MACD
- WISA 0.01
- CLRB -0.11
- Stochastic Oscillator
- WISA 62.50
- CLRB 1.41
About WISA WiSA Technologies Inc.
WiSA Technologies Inc is a provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.. The company works with consumer electronics companies, technology providers, retailers, and ecosystem partners to make immersive audio an enjoyable experience. The company has a geographic presence in Asia Pacific, North America, Europe and, other.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.